AprilBio

IPO

AprilBio is a biotech company in Chuncheon, South Korea, founded in 2013. It has raised $251.1M across 1 round, most recently a $251.1M Corporate Round in June 2026.

SAFA enhances efficacy, safety and half-life

Headquarters
Chuncheon
Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$251.1M
Last Round
$251.1M Corporate RoundJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

AprilBio Co., Ltd. is a South Korean biopharmaceutical company founded in 2013 and headquartered in Chuncheon, Gangwon Province, specializing in the development of innovative therapeutics using its proprietary SAFA™ (anti-Serum Albumin Fab Associated) platform technology. The SAFA platform fuses human antibody fragments with an albumin binder to enhance drug efficacy, extend half-life, and minimize immunogenicity, enabling the development of next-generation treatments for autoimmune diseases and oncology. AprilBio's lead asset APB-A1, licensed to Lundbeck in a deal valued at up to $448M, has progressed through Phase 1b clinical trials, and the company secured approximately $247M (₩3,467 billion) in strategic investment from TKG Group and IMM Investment in 2026 to accelerate its expanding REMAP platform pipeline.

Summary

It lists 51–200 employees. It has raised $251.1M in total across 1 round, most recently a $251.1M Corporate Round in Jun 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundThird-Party AllotmentJun 2026
$251.1M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AprilBio on Indexed.vc
<a href="https://indexed.vc/companies/aprilbio"><img src="https://indexed.vc/api/badge/company/aprilbio" alt="AprilBio on Indexed.vc" width="260" height="76" /></a>